| Table 2. Endometrial thickness. pathology and citometry among group: control. RIF pretreatment and post treatment. Multiple comparison | ||||
| Variables | Control |
RIF Pretreatment |
RIF Posttreatment |
P |
| Endometrial thickness (mm) | 9.5±1.2(7.5-11)* | 8.77±2.12(6-13)† | 9.77±3.35(5.7-13)‡ | 0.047†‡ |
| Abnormal pathology | - | 16/30(53.3)† | 5/30(16.6)‡ | 0.0012†‡ |
| Flow Cytometry (FC) | ||||
| Li/PC | 10.1±4.4(4-16)* | 17.3±8.2(4-35)† | 8.9±8.3(2-45)‡ | 0.01*† 0.002†‡ |
| LT/Li | 46.8±24.8(2-85) | 46.6±19.3(11-77) | 49.3±18.09(14-81) | NS |
| LB/Li | 2.9±2.4(0-7) | 2.2±2.2(0-8) | 2.25±1.7(0-7) | NS |
| NK/Li | 40.2±21.6(13-68) | 48.02±20.9(19-88) | 47.08±18.2(15-85) | NS |
| CD3+CD4/LTCD3+ | 44±8.15(29-56) | 48.1±11.8(20-69) | 43.6±10.2(20-65) | NS |
| CD3+CD8/LTCD3+ | 53.2±8.52(42-66) | 51.6±10.7(31-80) | 54.7±8.9(35-80) | NS |
| CD4/CD8 | 0.92±0.26(0-1) | 1.02±0.45(0.25-2.22) | 0.85±0.3(0.25-1.85) | NS |
| NKCD56dimCD16bright/NK | 14.5±7.32(4-30) | 14.42±11.44(3-48) | 17.94±12.03(4-44) | NS |
| NKCD56brightCD16dim/NK | 84.07±8.02(68-96) | 83.63±13.77(41-97) | 80.14±12.37(55-96) | NS |